Intervention Review

Caffeine versus theophylline for apnea in preterm infants

  1. David J Henderson-Smart1,
  2. Peter A Steer2

Editorial Group: Cochrane Neonatal Group

Published Online: 20 JAN 2010

Assessed as up-to-date: 17 AUG 2009

DOI: 10.1002/14651858.CD000273.pub2


How to Cite

Henderson-Smart DJ, Steer PA. Caffeine versus theophylline for apnea in preterm infants. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD000273. DOI: 10.1002/14651858.CD000273.pub2.

Author Information

  1. 1

    Faculty of Medicine, University of Sydney, (Deceased) Central Clinical School, Sydney, Australia

  2. 2

    Children's Health Services District, Queensland Health, School of Medicine, Faculty of Health Sciences, University of Queensland, Brisbane, Queensland, Australia

*Diane Haughton, Department of Pediatrics and Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, CRL, Room B102, Hamilton, Ontario, L8S 4K1, Canada. haughton@mcmaster.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 JAN 2010

SEARCH

  1. Current Version

    Caffeine versus theophylline for apnea in preterm infants

    David J Henderson-Smart and Peter A Steer

    Article first published online: 20 JAN 2010 | DOI: 10.1002/14651858.CD000273.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Caffeine versus theophylline for apnea in preterm infants

    Peter A Steer and David J Henderson-Smart

    Article first published online: 27 APR 1998 | DOI: 10.1002/14651858.CD000273